Immune cells and hypertension

Area of Science:

• Cardiovascular Disease Research
• Immunology
• Hypertension Pathogenesis

Background:

• Hypertension is a major cause of mortality linked to target organ damage.
• Current treatments are insufficient, with only one-sixth of patients achieving effective blood pressure control.
• Understanding hypertension's underlying mechanisms, particularly the role of immune cells, is critical.

Purpose of the Study:

• To review the current research on the involvement of various immune cells in the pathogenesis of hypertension.
• To elucidate the mechanisms by which immune cells contribute to hypertension-related organ damage.

Main Methods:

• Review of existing scientific literature on immune cells and hypertension.
• Analysis of the roles of innate and adaptive immune cells (monocytes/macrophages, neutrophils, dendritic cells, NK cells, B and T lymphocytes).
• Examination of immune cell infiltration in cardiovascular tissues and their secreted factors.

Main Results:

• Immune cells infiltrate blood vessels, kidneys, and hearts, causing damage.
• Immune cells secrete cytokines (e.g., interleukin, interferon, tumor necrosis factor) that influence inflammation, oxidative stress, and renal function.
• These processes contribute to cardiovascular dysfunction, remodeling, and fibrosis, impacting blood pressure regulation.

Conclusions:

• Immune cell activity is a key factor in hypertension development and progression.
• Targeting immune responses presents a potential therapeutic strategy for managing hypertension and its complications.